Bendigo buy marijuana

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Bendigo buy marijuana

ABC Central Victoria. Topic: Alternative Medicine. Terry Russell uses cannabis oil for pain relief but wants it safe and meeting Australian standards. When Terry Russell faced crippling, chronic back and leg pain he was prescribed a debilitating dosage of opioids. As an alternative, the year-old tried medicinal cannabis and now takes three small amounts of cannabis oil each day, which he says helps. Terry Russell's bottle of cannabis oil. Mr Russell is one of about , Australians currently prescribed cannabis by their doctor for medicinal purposes. The little bottle he picks up from his pharmacy reads 'Australian made', but that doesn't mean it is made from Australian ingredients. He felt deceived when he discovered that the cannabis he relies on may not necessarily be grown in Australia or subject to stringent Australian regulations. Nan-Maree Schoerie says differing standards are hurting Australian-based medicinal cannabis growers. Standing among towering cannabis plants, she said Australian growers worked to strict regulations not seen in other parts of the world. But under rules enforced by the Therapeutic Goods Administration TGA , medicinal cannabis products sold to Australian consumers can be grown anywhere in the world. Nan-Maree Schoerie says it costs Australian growers about 30 per cent more to produce cannabis. It is up to the cannabis importer to ensure production standards laid out under the Therapeutic Goods Act are met, but the cannabis may not be subjected to the same level of testing. Ms Schoerie said that 'loophole' allowed importers to cut costs and undercut domestic growers. Dan Howard says regulations need to be enforced to ensure accurate labelling for imported ingredients. Tasmanian grower Dan Howard said there was no guarantee imported cannabis was tested to Australian standards. Like Mr Russell, Mr Howard described the lack of transparency as deceptive. Peter Comerford has been in the medicinal cannabis industry for 30 years and runs the manufacturer, TCann, as well as NSW-based importer Anspec. He says his companies reject poor quality products and refuse to accept products unless they have been tested in independent labs and comply with Australian standards. He agreed there needed to be tougher regulations for the medicinal cannabis industry. Cann Group grows medicinal cannabis at a secret facility in Mildura, Victoria. A major Australian laboratory responsible for testing cannabis products estimates about 30 per cent of imports from Canada — the largest supplier of cannabis to Australia — do not match the strength of the active ingredients listed on the label. The operator asked not to be identified, citing commercial sensitivities. It claimed that up to 20 per cent of material grown overseas and imported could also contain microbiological contaminants. An ECS Botanics worker packs cannabis bud into a container to send to the market. The TGA is concerned about the rise in the number of Australians taking medicinal cannabis. At a conference in Melbourne last month the body's chief medical officer Robyn Langham said about 1. The TGA has since backtracked on that figure, stating 'the real patient count is unknown', but has confirmed , medicinal cannabis products were prescribed in Professor Langham told the conference the regulatory body was overwhelmed by demand. The TGA does not routinely test imported or domestic cannabis products and says it is not its role to test every medicine that enters Australia. Steve Robson says more data and transparency about medicinal cannabis is needed. He said doctors did not have enough information about the quality of cannabis or how rigorously it was tested. TGA data shows there have been six reported cases of people having adverse reactions to prescribed cannabis since Peter Koetsier says the federal government needs to intervene for a viable medicinal cannabis industry. But last month, the Australian Stock Exchange-listed company — one of Australia's oldest cannabis producers — was suspended from trading amid cash flow troubles. Now Cann Group is trying to offload its Mildura site to recoup funds and outgoing chief executive Peter Koetsier says the competition from unregulated cannabis imports is partly to blame. Cann Group plans to reduce staff and sell its Mildura site. ABC News. Mr Koetsier said he had been urging government to change the regulatory framework to require imported products were tested to ensure they met Australian standards. Terry Russell says he is concerned about taking adulterated cannabis oil. Mr Russell says it is important that he gets the 'real deal'. We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work. Imported medicinal cannabis sold without testing for Australian standards, industry warns. Imported medicinal cannabis sold without testing for Australian standards, industry warns By Tyrone Dalton and Else Kennedy for Stateline. Email address. Footer ABC News homepage.